Ratings by Evercore ISI (Ross Muken)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/4/2025 | Twist Bioscience | TWST | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2025 | Twist Bioscience | TWST | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2025 | Henry Schein | HSIC | Maintain | In Line (N/A) |
|
Details | ||
| 8/28/2024 | Patterson Companies | PDCO | Maintain | In Line (N/A) |
|
Details | ||
| 2/29/2024 | Patterson Companies | PDCO | Maintain | In Line (N/A) |
|
Details | ||
| 2/27/2024 | Henry Schein | HSIC | Maintain | In Line (N/A) |
|
Details | ||
| 11/17/2023 | Twist Bioscience | TWST | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2023 | Twist Bioscience | TWST | Maintain | Outperform (N/A) |
|
Details | ||
| 5/24/2023 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2023 | Patterson Companies | PDCO | Maintain | In Line (N/A) |
|
Details | ||
| 2/3/2023 | Twist Bioscience | TWST | Maintain | Outperform (N/A) |
|
Details | ||
| 1/3/2023 | Twist Bioscience | TWST | Upgrade | Outperform (In Line) |
23.81 (142.39) |
498.03% | Details | |
| 12/2/2022 | Patterson Companies | PDCO | Maintain | In Line (N/A) |
|
Details | ||
| 9/1/2022 | Patterson Companies | PDCO | Maintain | In Line (N/A) |
|
Details | ||
| 8/9/2022 | eHealth | EHTH | Maintain | In Line (N/A) |
|
Details | ||
| 5/25/2022 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2022 | Twist Bioscience | TWST | Maintain | In Line (N/A) |
|
Details | ||
| 5/3/2022 | Henry Schein | HSIC | Maintain | In Line (N/A) |
|
Details | ||
| 3/3/2022 | Patterson Companies | PDCO | Maintain | In Line (N/A) |
|
Details | ||
| 3/2/2022 | eHealth | EHTH | Downgrade | In Line (Outperform) |
15.54 (1.24) |
-92.02% | Details | |
| 2/23/2022 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 12/2/2021 | Patterson Companies | PDCO | Maintain | In Line (N/A) |
|
Details | ||
| 11/8/2021 | eHealth | EHTH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2021 | ICON plc | ICLR | Maintain | Outperform (N/A) |
|
Details | ||
| 1/4/2021 | Twist Bioscience | TWST | Downgrade | In Line (Outperform) |
141.29 (142.39) |
0.78% | Details | |
| 1/2/2020 | Henry Schein | HSIC | Upgrade | In Line (Underperform) |
66.72 (68.47) |
2.62% | Details | |
| 11/14/2019 | Qiagen NV | QGEN | Upgrade | Outperform (In Line) |
35.45 (44.50) |
25.53% | Details | |
| 8/30/2019 | Patterson Companies | PDCO | Maintain | In Line (N/A) |
|
Details | ||
| 7/16/2019 | Qiagen NV | QGEN | Downgrade | In Line (Outperform) |
39.69 (35.45) |
-10.68% | Details | |
| 5/31/2019 | Twist Bioscience | TWST | New Coverage | Outperform (N/A) |
25.80 (142.39) |
451.9% | Details | |
| 4/10/2019 | AmerisourceBergen | ABC | Downgrade | In Line (Outperform) |
78.12 (105.53) |
35.09% | Details | |
| 2/4/2019 | eHealth | EHTH | New Coverage | Outperform (N/A) |
61.16 (1.24) |
-97.97% | Details | |
| 1/3/2019 | Mettler-Toledo | MTD | Downgrade | Underperform (In Line) |
565.58 (1425.09) |
151.97% | Details | |
| 1/3/2019 | Patterson Companies | PDCO | Upgrade | In Line (Underperform) |
19.66 (31.33) |
59.36% | Details | |
| 1/3/2019 | Henry Schein | HSIC | Downgrade | Underperform (In Line) |
78.52 (89.29) |
13.72% | Details | |
| 11/12/2018 | athenahealth | ATHN | Downgrade | In Line (Outperform) |
120.35 (9.59) |
-92.03% | Details | |
| 10/26/2018 | ICON plc | ICLR | Upgrade | Outperform (In Line) |
131.58 (172.49) |
31.09% | Details | |
| 10/12/2018 | Allscripts | MDRX | Downgrade | In Line (Outperform) |
13.49 (4.96) |
-63.23% | Details | |
| 8/15/2018 | Agilent | A | Maintain | Outperform (N/A) |
|
Details |
